Russell Investments Group’s Neuronetics STIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.5K Buy
8,839
+5,582
+171% +$8.12K ﹤0.01% 3910
2026
Q1
$4.72K Buy
3,257
+50
+2% +$79 ﹤0.01% 3902
2025
Q4
$4.43K Buy
3,207
+212
+7% +$444 ﹤0.01% 3923
2025
Q3
$8.18K Buy
+2,995
New +$10.6K ﹤0.01% 3826
2021
Q3
Sell
-206,090
Closed -$3.3M 3207
2021
Q2
$3.3M Sell
206,090
-105,352
-34% -$1.46M 0.01% 1613
2021
Q1
$3.85M Buy
311,442
+197,059
+172% +$3.02M 0.01% 1494
2020
Q4
$1.27M Buy
114,383
+101,805
+809% +$765K ﹤0.01% 2004
2020
Q3
$61K Buy
+12,578
New +$47.7K ﹤0.01% 3055
2020
Q1
Sell
-35,014
Closed -$156K 3129
2019
Q4
$156K Buy
+35,014
New +$218K ﹤0.01% 2782
2018
Q4
Sell
-12,056
Closed -$387K 3029
2018
Q3
$387K Sell
12,056
-549
-4% -$16.7K ﹤0.01% 2499
2018
Q2
$335K Buy
+12,605
New +$343K ﹤0.01% 2514

Other funds holding STIM

Russell Investments Group's STIM Position: Q2 2026 in Review

Russell Investments Group increased its Neuronetics (STIM) stake by 171% in Q2 2026, buying an estimated $8.12K and bringing the position to 8,839 shares worth $11.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3910.

Russell Investments Group first reported a position in STIM in Q2 2018 and has held it in 11 quarters since. The position peaked at $3.85M in Q1 2021. 23 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • Russell Investments Group held 8,839 shares of Neuronetics worth $11.5K as of Q2 2026.
  • Russell Investments Group bought 5,582 Neuronetics shares in Q2 2026, an estimated $8.12K.
  • Neuronetics made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3910 holding.
  • Russell Investments Group first reported a position in Neuronetics in Q2 2018 and has held it in 11 quarters since.
  • Russell Investments Group's Neuronetics position peaked at $3.85M in Q1 2021.
  • 23 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.